Nattokinase Market
Nattokinase Market Study by 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU Purity in Stabilizers, Antithrombotic Agents, and Others from 2023 to 2033
Analysis of Nattokinase Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Nattokinase Market Outlook (2023 to 2033)
Worldwide sales of nattokinase are estimated at US$ 35.57 million in 2023 and are forecasted to climb to US$ 47.35 million by 2033-end. The global nattokinase market is predicted to exhibit expansion at 2.9% CAGR over the next ten years.
Nattokinase is an enzyme that is obtained from a Japanese food called Natt?, which is made by fermentation of boiled soybeans by adding the bacterium Bacillus natto. Nattokinase has a cheese-like flavour and numerous health benefits that are anticipated to propel its demand over the coming years.
Increasing investments in research and development programs to know more about the benefits of natto and nattokinase, increasing consumption of plant-based dietary supplements, the rising popularity of plant-based foods and veganism, and heightened focus on fitness are some key aspects that could influence the consumption of nattokinase going forward.
- In May 2023, a study by a research team at Osaka Metropolitan University’s Graduate School of Human Life and Ecology revealed that eating natto might help people to distress and possibly improve lifespan extendibility.
High prevalence of lifestyle disorders and chronic diseases coupled with the rapidly increasing aging population on a global scale is slated to set the stage for nattokinase companies to expand their business lucratively. Several benefits associated with the use of nattokinase tablets to treat various diseases are also anticipated to offer rewarding business scope across the forecast period.
New plant-based product companies are focusing on incorporating nattokinase in their products to meet the evolving demand from their consumers. An innovative approach towards using nattokinase powder and nattokinase tablets in different products to give them a unique taste and nutritional profile could open up new moneymaking opportunities for nattokinase suppliers as well as other companies involved.
- In 2020, Zoh Probiotics, a manufacturer of probiotic products based in India, revealed its plans of adding natto to its DIY product range, which it did later in 2020. The company is well known for its kombucha and other fermented products that promote gut health.
On the flip side, the absence of research data for the long-term effects of nattokinase consumption and the lack of credible information regarding nattokinase could potentially take a chunk out of the global nattokinase market share over the next ten years.
A detailed account of industry-altering aspects such as new developments, product standards, local supply, pricing trends, and safety regulations have been mentioned in this latest nattokinase market study by Fact.MR.
| Report Attributes | Details |
|---|---|
|
Nattokinase Market Size (2023) |
US$ 35.57 Million |
|
Projected Market Value (2033F) |
US$ 47.35 Million |
|
Global Market Growth Rate (2023 to 2033) |
2.9% CAGR |
|
Market Value of United States (2033F) |
US$ 11.93 Million |
|
Germany Market Growth Rate (2023 to 2033) |
3.7% CAGR |
|
Japan Market Value (2033F) |
US$ 5.96 Million |
|
China Market Value (2023) |
US$ 4.73 Million |
|
Historical Global Market Growth Rate (2018 to 2022) |
2% CAGR |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Trend Will Influentially Determine the Future of Nattokinase Sales?
“Surging Popularity of Plant-based Supplements”
The globally popular trend of veganism has had a huge impact on different aspects of life and this trend is projected to play a crucial role in shaping the natto industry size in the future. Growing awareness regarding the ill effects of synthetic ingredients and changing consumer preferences are anticipated to promote sales of plant-based supplements and plant-based food products over the next ten years.
New nattokinase companies could focus on making products that are completely plant-based to satisfy evolving consumer demands and grow their business in a lucrative way.
More detailed insights on how new companies and established companies can benefit from the plant-based trend have been mentioned in this latest nattokinase research survey by the skilled analysts at Fact.MR, a market research and competitive intelligence provider.
Country-wise Insights
How Does This Research Define the United States Market?
“Surging Prevalence of Cardiovascular Disorders and Diabetes – Prime Growth Initiator”
Obesity has become a widespread issue in the United States in recent years and this has resulted in a notable increase in the number of people suffering from cardiac disorders. The adoption of a sedentary lifestyle coupled with poor eating habits is also anticipated to benefit the growth of the nattokinase market in the country over the next ten years.
- Heart disease is the leading cause of death in the United States and around 695,000 people suffered loss of life due to the same in the year 2021. These statistics are provided by the Centers for Disease Control and Prevention (CDC).
Rising prevalence of diabetes, high awareness regarding fitness, expanding hypertensive population, and growing demand for functional foods and superfoods are other factors that are projected to uplift consumption of nattokinase across the forecast period in the country.
- Sales of nattokinase in the United States are forecasted to rake in a value of US$ 11.93 million by 2033-end and are estimated to rise at a modest 3.2% CAGR over the next ten years.
Are European Country Investment-worthy Markets for Nattokinase Suppliers?
“High Preference for Plant-based Ingredients and Increasing Health Awareness Offering Lucrative Business Scope”
Preference for plant-based and vegan foods has increased exponentially in recent years in most European countries, which is projected to decidedly augment nattokinase demand over the coming years. The presence of key food manufacturers and their efforts to incorporate natural ingredients in their products is also a major trend that makes European countries highly remunerative spaces in the future.
Expanding geriatric population, high prevalence of chronic diseases and lifestyle disorders, supportive government initiatives, and growing focus on health are other prospects that could bolster nattokinase product sales over the next ten years.
- Sales of nattokinase in the United Kingdom are predicted to increase at 3.5% CAGR over the next ten years to attain a value of US$ 3.55 million by the end of 2033.
Which Countries are Remunerative Spaces in the APAC Region?
“Japan and China to Offer Rewarding Business Opportunities”
Natto is a soy-based traditional dish of Japan and is the primary source for nattokinase extraction. The high popularity of natto as a cheap and nutritious breakfast in Japan has made people accustomed to the taste of nattokinase. The increasing senescent population and growing demand for plant-based natural dietary supplements are also predicted to uplift shipments of nattokinase over the next ten years.
- Demand for nattokinase in Japan is predicted to increase at 3.6% CAGR over the next ten years and accumulate a revenue of US$ 5.96 million by 2033-end.
- In March 2023, The Japan natto cooperative society federation announced the launch of its new website’s Chinese version. The initiative is part of the federation’s effort to promulgate the popularity of Natto to the world as it has supported the health of Japanese people immensely. China could witness a notable hike in the popularity of natto and nattokinase-based products following this development.
China and Japan have been closely influencing each other’s culture and food, which is a key prospect that is estimated to push nattokinase companies to invest in the Chinese marketplace. The growing popularity of plant-based food trends and evolving consumer preferences in China are predicted to create an opportune scenario for nattokinase vendors going forward.
- Nattokinase sales in China are extrapolated to secure a revenue valuation of US$ 6.67 million by the end of the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Nattokinase of Which Purity Accounts for a Dominant Market Share?
"2,000 to 5,000 FU Purity Nattokinase to Maintain Hegemony"
Based on purity FU (Fibrin Units), the nattokinase market is segmented into 2,000 to 5,000 FU, 5,000 to 10,000 FU, 10,000 to 15,000 FU, and 15,000 to 20,000 FU.
Nattokinase with 2,000 to 5,000 FU purity is projected to account for a prominent share in the global marketplace throughout the forecast period. The recommended safe dosage of nattokinase is found to be 100 to 200 mg per day, which is the equivalent of 2,000 to 5,000 FU and hence contributes to the high share of this segment in the global industry landscape.
- Shipments of nattokinase with 2,000 to 5,000 FU purity are projected to rise at 3.2% CAGR through 2033.
Where is Nattokinase Being Used Extensively?
“Pharmaceutical Formulations to Lead Revenue Generation”
Based on application, the nattokinase market is segmented into pharmaceutical formulations and nutraceutical formulations.
Use of natural ingredients in pharmaceutical formulations is increasing at a rapid pace owing to surging demand for pharmaceuticals around the world. Increasing awareness regarding the medical and health benefits associated with the consumption of nattokinase is also favoring its use in the pharmaceutical industry.
- Use of nattokinase in pharmaceutical formulations is estimated to rise at 3.6% CAGR over the next ten years.
Competitive Landscape
Key producers of nattokinase are focusing on research and development of novel products to enhance their revenue generation capacity on a global level.
- Sungen Bioscience Co. Ltd., a leading name in the global nattokinase industry signed an agreement with Shenyang Pharmaceutical University in July 2020 to develop a new form of biologic nattokinase injection and oral preparation.
A comprehensive and exhaustive analysis of all key market developments has been exclusively mentioned and discussed in this latest nattokinase research report by skilled analysts at Fact.MR.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments of Nattokinase Industry Research
-
By Purity FU (Fibrin Units) :
- 2,000 to 5,000 FU
- 5,000 to 10,000 FU
- 10,000 to 15,000 FU
- 15,000 to 20,000 FU
-
By Function :
- Stabilizers
- Antithrombotic Agents
- Anti-Inflammatory Agents
- Blood Pressure Regulators
- Inhibitors
-
By Application :
- Nutraceuticals (Formulations)
- Pharmaceutical (Formulations)
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Global Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Nattokinase 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2022 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Source Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Nattokinase 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Market Demand (US$ Mn) Analysis 2018 to 2022 and Forecast, 2023 to 2033 5.1. Historical Market Value (US$ Mn) Analysis, 2018 to 2022 5.2. Current and Future Market Value (US$ Mn) Projections, 2023 to 2033 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Purity FU (Fibrin Units) 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Purity FU (Fibrin Units), 2018 to 2022 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Purity FU (Fibrin Units), 2023 to 2033 6.3.1. 2,000 to 5,000 FU 6.3.2. 5,000 to 10,000 FU 6.3.3. 10,000 to 15,000 FU 6.3.4. 15,000 to 20,000 FU 6.4. Market Attractiveness Analysis By Purity FU (Fibrin Units) 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Function 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Function, 2018 to 2022 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Function, 2023 to 2033 7.3.1. Stabilizers 7.3.2. Antithrombotic Agents 7.3.3. Anti-Inflammatory Agents 7.3.4. Blood Pressure Regulators 7.3.5. Inhibitors 7.4. Market Attractiveness Analysis By Function 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By Application, 2018 to 2022 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2023 to 2033 8.3.1. Nutraceuticals (Formulations) 8.3.2. Pharmaceutical (Formulations) 8.4. Market Attractiveness Analysis By Application 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2018 to 2022 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2023 to 2033 10.3.1. By Country 10.3.1.1. United States 10.3.1.2. Canada 10.3.2. By Purity FU (Fibrin Units) 10.3.3. By Function 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Purity FU (Fibrin Units) 10.4.3. By Function 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Purity FU (Fibrin Units) 11.3.3. By Function 11.3.4. By Application 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Purity FU (Fibrin Units) 11.4.3. By Function 11.4.4. By Application 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. United Kingdom 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Purity FU (Fibrin Units) 12.3.3. By Function 12.3.4. By Application 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Purity FU (Fibrin Units) 12.4.3. By Function 12.4.4. By Application 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Purity FU (Fibrin Units) 13.3.3. By Function 13.3.4. By Application 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Purity FU (Fibrin Units) 13.4.3. By Function 13.4.4. By Application 14. South Asia & Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Purity FU (Fibrin Units) 14.3.3. By Function 14.3.4. By Application 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Purity FU (Fibrin Units) 14.4.3. By Function 14.4.4. By Application 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2023 to 2033 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Purity FU (Fibrin Units) 15.3.3. By Function 15.3.4. By Application 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Purity FU (Fibrin Units) 15.4.3. By Function 15.4.4. By Application 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. NutraCap Labs 17.3.1.1. Company Overview 17.3.1.2. Source overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. Infinita Biotech Private Limited 17.3.2.1. Company Overview 17.3.2.2. Source overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. BIOVEN INGREDIENTS 17.3.3.1. Company Overview 17.3.3.2. Source overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. PHARMANAGER INGREDIENTS 17.3.4.1. Company Overview 17.3.4.2. Source overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Xi'an Herb Bio-Tech Co. Ltd. 17.3.5.1. Company Overview 17.3.5.2. Source overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. GeneFerm Biotechnology Co. Ltd. 17.3.6.1. Company Overview 17.3.6.2. Source overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Contek Life Science Co. Ltd. 17.3.7.1. Company Overview 17.3.7.2. Source overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. Japan Bio Science Laboratory 17.3.8.1. Company Overview 17.3.8.2. Source overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Sungen Bioscience Co. Ltd. 17.3.9.1. Company Overview 17.3.9.2. Source overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Belle Chemical 17.3.10.1. Company Overview 17.3.10.2. Source overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 17.3.11. Hexon Laboratories Private Limited 17.3.11.1. Company Overview 17.3.11.2. Source overview 17.3.11.3. SWOT Analysis 17.3.11.4. Key Developments 17.3.12. RAJVI ENTERPRISE 17.3.12.1. Company Overview 17.3.12.2. Source overview 17.3.12.3. SWOT Analysis 17.3.12.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 02: Global Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 04: Global Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 05: Global Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 07: Global Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 08: Global Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2022
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2023 to 2033
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2023 to 2033
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 16: North America Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 17: North America Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 19: North America Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 20: North America Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 22: North America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 23: North America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 28: Latin America Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 29: Latin America Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 31: Latin America Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 32: Latin America Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 34: Latin America Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 35: Latin America Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 40: Europe Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 41: Europe Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 43: Europe Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 44: Europe Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 46: Europe Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 47: Europe Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 52: East Asia Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 53: East Asia Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 55: East Asia Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 56: East Asia Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 58: East Asia Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 59: East Asia Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2022
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2023 to 2033
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2023 to 2033
Table 76: MEA Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2018 to 2022
Table 77: MEA Market Value (US$ Mn) Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Purity FU (Fibrin Units), 2023 to 2033
Table 79: MEA Market Value (US$ Mn) Analysis, by Function, 2018 to 2022
Table 80: MEA Market Value (US$ Mn) Analysis, by Function, 2023 to 2033
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Function, 2023 to 2033
Table 82: MEA Market Value (US$ Mn) Analysis, by Application, 2018 to 2022
Table 83: MEA Market Value (US$ Mn) Analysis, by Application, 2023 to 2033
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Application, 2023 to 2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 04: Global Market Incremental $ Opportunity, 2023 to 2033
Figure 05: Global Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 06: Global Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 07: Global Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 08: Global Market Share and BPS Analysis by Function, 2023 & 2033
Figure 09: Global Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 10: Global Market Attractiveness Analysis by Function, 2023 to 2033
Figure 11: Global Market Share and BPS Analysis by Application, 2023 & 2033
Figure 12: Global Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 13: Global Market Attractiveness Analysis by Application, 2023 to 2033
Figure 14: Global Market Share and BPS Analysis by Region, 2023 & 2033
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2023 to 2033
Figure 16: Global Market Attractiveness Analysis by Region, 2023 to 2033
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2033
Figure 20: North America Market Incremental $ Opportunity, 2023 to 2033
Figure 21: North America Market Share Analysis by Country, 2023 & 2033
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 23: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 24: North America Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 25: North America Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 26: North America Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 27: North America Market Share and BPS Analysis by Function, 2023 & 2033
Figure 28: North America Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 29: North America Market Attractiveness Analysis by Function, 2023 to 2033
Figure 30: North America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 31: North America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 32: North America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 36: Latin America Market Incremental $ Opportunity, 2023 to 2033
Figure 37: Latin America Market Share Analysis by Country, 2023 & 2033
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 39: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 40: Latin America Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 41: Latin America Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 42: Latin America Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 43: Latin America Market Share and BPS Analysis by Function, 2023 & 2033
Figure 44: Latin America Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 45: Latin America Market Attractiveness Analysis by Function, 2023 to 2033
Figure 46: Latin America Market Share and BPS Analysis by Application, 2023 & 2033
Figure 47: Latin America Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 48: Latin America Market Attractiveness Analysis by Application, 2023 to 2033
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 52: Europe Market Incremental $ Opportunity, 2023 to 2033
Figure 53: Europe Market Share Analysis by Country, 2023 & 2033
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: Europe Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 57: Europe Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 58: Europe Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 59: Europe Market Share and BPS Analysis by Function, 2023 & 2033
Figure 60: Europe Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 61: Europe Market Attractiveness Analysis by Function, 2023 to 2033
Figure 62: Europe Market Share and BPS Analysis by Application, 2023 & 2033
Figure 63: Europe Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 64: Europe Market Attractiveness Analysis by Application, 2023 to 2033
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 68: East Asia Market Incremental $ Opportunity, 2023 to 2033
Figure 69: East Asia Market Share Analysis by Country, 2023 & 2033
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 71: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 72: East Asia Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 73: East Asia Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 74: East Asia Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 75: East Asia Market Share and BPS Analysis by Function, 2023 & 2033
Figure 76: East Asia Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 77: East Asia Market Attractiveness Analysis by Function, 2023 to 2033
Figure 78: East Asia Market Share and BPS Analysis by Application, 2023 & 2033
Figure 79: East Asia Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 80: East Asia Market Attractiveness Analysis by Application, 2023 to 2033
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2023 to 2033
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2023 & 2033
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Function, 2023 & 2033
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Function, 2023 to 2033
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Application, 2023 & 2033
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Application, 2023 to 2033
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2022
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2023 to 2033
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2033
Figure 100: MEA Market Incremental $ Opportunity, 2023 to 2033
Figure 101: MEA Market Share Analysis by Country, 2023 & 2033
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2023 to 2033
Figure 103: MEA Market Attractiveness Analysis by Country, 2023 to 2033
Figure 104: MEA Market Share and BPS Analysis by Purity FU (Fibrin Units), 2023 & 2033
Figure 105: MEA Market Y-o-Y Growth Projections by Purity FU (Fibrin Units), 2023 to 2033
Figure 106: MEA Market Attractiveness Analysis by Purity FU (Fibrin Units), 2023 to 2033
Figure 107: MEA Market Share and BPS Analysis by Function, 2023 & 2033
Figure 108: MEA Market Y-o-Y Growth Projections by Function, 2023 to 2033
Figure 109: MEA Market Attractiveness Analysis by Function, 2023 to 2033
Figure 110: MEA Market Share and BPS Analysis by Application, 2023 & 2033
Figure 111: MEA Market Y-o-Y Growth Projections by Application, 2023 to 2033
Figure 112: MEA Market Attractiveness Analysis by Application, 2023 to 2033
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current nattokinase market value?
The global nattokinase market accounts for a valuation of US$ 35.57 million in 2023.
How big will the nattokinase market be by 2033?
Demand for nattokinase is set to rake in a revenue of US$ 47.35 million by the end of 2033.
At what pace will the market develop going forward?
Shipments of nattokinase are predicted to increase at 2.9% CAGR over the next ten years.
What are the factors driving the nattokinase market?
Changing lifestyles, high prevalence of cardiovascular disorders, rising consumer awareness, and high demand for plant-based products are key market drivers.
What statistics are listed in this research for the market in the United States?
Nattokinase sales in the United States are projected to reach US$ 98.66 million by 2033, rising at 3.2% CAGR from 2023 to 2033.
Who are the leading manufacturers of nattokinase?
Contek Life Science Co. Ltd., Japan Bio Science Laboratory, Sungen Bioscience Co. Ltd., and Belle Chemical are prime nattokinase manufacturers.
Nattokinase Market